Cambiar Investors LLC Sells 5,738 Shares of Maximus, Inc. (NYSE:MMS)

Cambiar Investors LLC lessened its stake in Maximus, Inc. (NYSE:MMS) by 4.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 131,970 shares of the health services provider’s stock after selling 5,738 shares during the period. Cambiar Investors LLC’s holdings in Maximus were worth $12,294,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. increased its stake in Maximus by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 6,208,839 shares of the health services provider’s stock worth $520,922,000 after purchasing an additional 145,983 shares during the period. Janus Henderson Group PLC raised its holdings in Maximus by 2.1% during the 1st quarter. Janus Henderson Group PLC now owns 1,254,536 shares of the health services provider’s stock valued at $105,255,000 after buying an additional 25,825 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Maximus by 7.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,153,977 shares of the health services provider’s stock valued at $98,904,000 after buying an additional 79,092 shares during the period. Van Berkom & Associates Inc. grew its holdings in Maximus by 0.8% in the 2nd quarter. Van Berkom & Associates Inc. now owns 1,146,524 shares of the health services provider’s stock worth $98,257,000 after acquiring an additional 8,811 shares during the last quarter. Finally, Assenagon Asset Management S.A. increased its position in shares of Maximus by 277.0% in the third quarter. Assenagon Asset Management S.A. now owns 878,894 shares of the health services provider’s stock valued at $81,878,000 after acquiring an additional 645,760 shares during the period. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Maximus Stock Performance

Shares of NYSE:MMS opened at $86.96 on Friday. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.61. The company has a market cap of $5.23 billion, a price-to-earnings ratio of 18.23 and a beta of 0.76. Maximus, Inc. has a 12 month low of $74.79 and a 12 month high of $93.97. The company has a 50-day moving average price of $89.77 and a 200-day moving average price of $87.58.

Maximus (NYSE:MMS) last released its quarterly earnings data on Wednesday, August 7th. The health services provider reported $1.74 earnings per share for the quarter, topping the consensus estimate of $1.47 by $0.27. Maximus had a return on equity of 20.91% and a net margin of 5.59%. The business had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.29 billion. During the same quarter last year, the business posted $0.78 EPS. The business’s revenue was up 10.6% on a year-over-year basis. As a group, equities analysts anticipate that Maximus, Inc. will post 6.12 EPS for the current year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, November 30th. Shareholders of record on Friday, November 15th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.38%. The ex-dividend date of this dividend is Friday, November 15th. Maximus’s payout ratio is currently 25.16%.

Insiders Place Their Bets

In other news, insider Michelle F. Link sold 1,363 shares of Maximus stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total transaction of $126,159.28. Following the sale, the insider now owns 6,567 shares of the company’s stock, valued at approximately $607,841.52. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 1.40% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.